Marshall Wace
PRTK

Marshall Wace’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Marshall Wace’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$82.2K Buy
2021
Q4 		– Sell
2021
Q3 		$542K Sell
2021
Q2 		$1.72M Buy
2020
Q1 		– Sell
2019
Q4 		$163K Buy
2018
Q1 		– Sell
2017
Q4 		$862K Buy
2017
Q3 		$1.1M Buy
2017
Q2 		$942K Buy